Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

Bullboard (GREY:ATBPF)

View:
Post by Pronorvistaon Nov 08, 2023 12:34pm

ATE

Afternoon it will the big cleaning .
Comment by Amigo11on Nov 08, 2023 11:46am

RE:The stock

Will they issue stock down here ?
Post by Duster340on Nov 08, 2023 11:06am

The stock

has been bid up over doubled in about 2 weeks, a sell off will happen soon. maybe on news this week or with the financials report next week, because we no P2 start date is a long ways away, investors ...more  
Comment by Pronorvistaon Nov 08, 2023 10:59am

RE:ATE

Players sorry .
Post by Pronorvistaon Nov 08, 2023 10:58am

ATE

Possibly between $ 1,25 - $ 1,30  today , the big platers are back .
Comment by Mmmtrollon Nov 08, 2023 10:06am

RE:Strange

No but Dan locked in 250k shares at 56c or whatever. To be redeemed at 6 dollar
Comment by Benedictuson Nov 07, 2023 11:13pm

RE:AC/DC Albums for 200 Alex

Nice tie in there! That called for an immediate revisit to watch that music video. AC/DC...Legendary rockers!  I was most certainly a frustrated poster, watching for 2 years what became a rather ...more  
Comment by MrMugsyon Nov 07, 2023 10:44pm

RE:ATE

That's the interesting thing - we likely didn't pick up any new players.  The same old crowd is coming back and a few of their friends.  Let's see what happens when new money ...more  
Comment by MrMugsyon Nov 07, 2023 10:41pm

RE:Strange

Not really strange - they are getting additional RSUs while they wait.  
Comment by MrMugsyon Nov 07, 2023 10:38pm

RE:RE:RE:RE:ATE

Actually - all the time buying under 50 cents was a lot of fun but it didn't stay there long enough.  Accumulators can't get enough of those lows.
Comment by MrMugsyon Nov 07, 2023 10:36pm

RE:AC/DC Albums for 200 Alex

Agree completely and was thinking about market psychology with all these returnees.  I though am not in the black but knocking on heaven's door.  So close that I can taste it !!!
Post by Pronorvistaon Nov 07, 2023 7:31pm

ATE

A title closes strong , should normally be strong at the opening , increase in price and volume all the ingredients are in place .
Post by TheMadMonkon Nov 07, 2023 5:11pm

AC/DC Albums for 200 Alex

This 1980's Hard Rock album was the seventh studio album from the Australian music group AC/DC.  What is Back in Black?  To quote the great British rocker Brian Johnson "Well ...more  
Post by Pronorvistaon Nov 07, 2023 2:49pm

ATE

Volume start the US side too. Q:ATBPF - ANTIBE THERAPEUTICS INC - Website unknown - click to update 14:46:02 EST  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities